Teachers Retirement System of The State of Kentucky Sells 6,771 Shares of HealthEquity, Inc. $HQY

Teachers Retirement System of The State of Kentucky trimmed its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 14.3% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 40,612 shares of the company’s stock after selling 6,771 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in HealthEquity were worth $3,848,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Norges Bank bought a new position in HealthEquity during the second quarter worth $75,072,000. Westfield Capital Management Co. LP grew its stake in shares of HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after buying an additional 701,819 shares during the period. AQR Capital Management LLC grew its stake in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after buying an additional 661,795 shares during the period. Vanguard Group Inc. raised its stake in HealthEquity by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock worth $828,883,000 after buying an additional 243,549 shares during the period. Finally, Man Group plc boosted its holdings in HealthEquity by 1,331.8% in the second quarter. Man Group plc now owns 254,652 shares of the company’s stock worth $26,677,000 after acquiring an additional 236,867 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on HQY shares. KeyCorp boosted their price objective on HealthEquity from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, January 8th. BMO Capital Markets set a $85.00 price target on shares of HealthEquity in a research note on Tuesday, February 24th. BTIG Research lowered their price objective on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. JPMorgan Chase & Co. lifted their price objective on shares of HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Finally, The Goldman Sachs Group downgraded shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price for the company. in a research report on Friday, January 9th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average target price of $112.00.

Insider Activity

In related news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the sale, the executive vice president owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the transaction, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.50% of the company’s stock.

HealthEquity Stock Performance

Shares of HealthEquity stock opened at $81.15 on Thursday. The firm has a market capitalization of $6.93 billion, a P/E ratio of 37.22, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The business’s fifty day simple moving average is $83.82 and its 200 day simple moving average is $90.92. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $116.65.

HealthEquity (NASDAQ:HQY) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. The company had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.78 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.